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Objectives: Data on long‐term structural lung abnormalities in survivors of congenital
diaphragmatic hernia (CDH) is scarce. The purpose of this study was to develop a
chest computed tomography (CT) score to assess the structural lung sequelae in CDH
survivors and to study the correlation between the CT scoring and clinical parameters
in the neonatal period and at 1 year of follow‐up.
Methods: A prospective, clinical follow‐up program is organised for CDH survivors at
the University Hospital of Leuven including a chest CT at the age of 1 year. The CT
scoring used and evaluated, named CDH‐CT score, was adapted from the revised
Aukland score for chronic lung disease of prematurity.
Results: Thirty‐five patients were included. All CT scans showed some pulmonary
abnormalities, ranging from very mild to severe. The mean total CT score was
16 (IQR: 9‐23), with the greatest contribution from the subscores for decreased
attenuation (5; IQR: 2‐8), subpleural linear and triangular opacities (4; IQR: 3‐5), and
atelectasis/consolidation (2; IQR: 1‐3). Interobserver and intraobserver agreement
was very good for the total score (ICC coefficient > 0.9). Total CT score correlated
with number of neonatal days ventilated/on oxygen as well as with respiratory
symptoms and feeding problems at 1 year of age.
Conclusion: The CDH‐CT scoring tool has a good intraobserver and interobserver
repeatability and correlates with relevant clinical parameters. This holds promise for
its use in clinical follow‐up and as outcome parameter in clinical interventional
studies.
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1 | INTRODUCTION
Congenital diaphragmatic hernia (CDH) is a severe congenital
anomaly affecting 1 in 2000‐3000 newborns. The presence of
abdominal organs in the chest cavity is associated with pulmonary
hypoplasia and abnormal pulmonary vascular growth with ensuing
pulmonary hypertension.1
The survival of newborns with CDH has improved thanks to
delayed surgical repair and the use of standardized treatment
protocols.2 Fetoscopic endoluminal tracheal occlusion (FETO) is
being studied, with the aim to reduce mortality and morbidity.3
Among survivors, pulmonary sequelae, gastrointestinal disorders,
neurodevelopmental problems, musculoskeletal deformities, and
CDH recurrence are frequently reported, especially in the first
3 years of life and these morbidities warrant the need for long‐term
follow‐up programs.2,4 Pulmonary morbidity, such as chronic lung
disease (CLD), recurrent infections, and persistent pulmonary
hypertension are present in 30%‐50% of the CDH survivors.2,5‐7
A prospective clinical follow‐up program for CDH survivors at the
age of 1 year was started in 2007 at the University Hospital of
Leuven, a tertiary neonatal and pediatric referral center. Apart from
a structured clinical evaluation, a respiratory questionnaire, and a
cardiac ultrasound,8 this follow‐up program includes an evaluation of
structural lung sequelae with chest computed tomography (CT).
Although other follow‐up programs included chest radiographs,
scintigraphy or magnetic resonance imaging (MRI), limited data are
available in literature on structural lung abnormalities in CDH
survivors after the neonatal age1,5‐7,9 or on the correlation with later
clinical and lung function parameters.10
The purpose of performing chest CT scans is to document the
structural lung sequelae at age 1 and to correlate them with prenatal and
neonatal parameters as well as clinical outcome. Our hypothesis is that
structural lung sequelae will cover a broad spectrum from very subtle to
very severe lung damage and that certain prenatal and neonatal
parameters will correlate with the extent of the CT abnormalities.
For standardized analysis, we developed a CDH‐CT scoring system
adapted from the revised Aukland score for bronchopulmonary dysplasia
(BPD, further referred to as CLD of prematurity). We report on the
validation of the proposed scoring system, the clinical impact of the CT
results, as well as on the correlation between the CT scoring and clinical
parameters in the neonatal period and at 1 year of follow‐up.
2 | MATERIALS AND METHODS
2.1 | Participants
Inclusion criteria were: babies admitted to our neonatal intensive
care unit, with a prenatal or postnatal diagnosis of CDH. Treatment
with FETO has been offered in case of prenatal diagnosis of CDH
with moderate to severe mortality risk. All patients invited for follow‐
up between January 2007 and August 2015 at the age of 1 year were
eligible for inclusion. Exclusion criteria were: babies not surviving the
neonatal period, babies referred from abroad for treatment of CDH
who were referred back to their country of origin for follow‐up
and care after the neonatal period, parents not giving consent for
follow‐up, incomplete follow‐up data, failed CT scan.
2.2 | CT imaging
An unenhanced low dose CT scan of the lungs (Somatom Sensation
64; Siemens Medical Solutions, Erlangen, Germany) was performed
around the age of 1 year. CT parameters were 100 kV, 45mA·s with
an automatic exposure control system (Care dose, Siemens Medical
Solutions), 64 × 0.6mm collimation, pitch of 1.4, 0.5 second rotation
time resulting in a volume CT dose index of approximately 2mGy.
Scanning was carried out with the child in supine position, during
quiet breathing (performing in—and expiration CT scans) and with
sedation (intrarectal chloral hydrate 100mg/kg or intrarectal
pentobarbital 5 mg/kg or intramuscular promethazine 0.5 mg/kg with
chlorpromazine 0.5 mg/kg. In one patient chest CT was performed
just before extubation after prolonged respiratory failure secondary
to a gastric pull through operation for congenital esophageal atresia.
The CT images were anonymized by an independent adminis-
trator to allow blinded scoring. All images were displayed at a
window width of 1500Hounsfield unit (HU) and window level of
−500HU with 1mm slice thickness. OsiriX Lite (Pixmeo, Bernex,
Switzerland) was used as workstation for scoring.
2.3 | Adaptation of the CT scoring system
We developed a new CT scoring system based on the revised
Aukland score for CLD of prematurity (Table SI).11,12
CT scans were reviewed and the most frequent structural
abnormalities were listed and combined with the revised Aukland
score.11 Ground glass opacities was added to the scoring system.
The modified scoring system (Table SI) included seven parameters;
we scored inspiratory CT scans for all five lobes and the lingula for the
presence (1) or absence (0) of linear/triangular subpleural opacities,
bullae, bronchiectasis, and bronchial wall thickening with 6 as
maximum score for each parameter. We also scored each lobe for
the presence of decreased attenuation, ground glass opacities, and
atelectasis/consolidation. These parameters were scored as absent (0),
present in less than one‐third of a lobe (1), present in one‐third to two‐
thirds of a lobe (2) or present in more than two‐thirds of a lobe (3) (see
CT images in Figure SII). The scoring item “ground glass opacity” is a
nonspecific finding on CT scans that indicates a partial filling of air
spaces in the lungs by exudate or transudate, as well as interstitial
thickening or partial collapse of lung alveoli. It may be difficult
to differentiate from regions of high attenuation resulting from
hyperperfusion related to the lung hypoplasia.
The different weight in the scoring for the different items was
considered to reflect their respective impact on lung damage. This
modified scoring system resulted theoretically in maximal total score
of 66 but in practice of 54 as atelectasis, decreased attenuation, and
ground glass are mutually exclusive.
Bullae were defined as focal regions of emphysema without
discernible wall and larger than 1 cm in diameter, bronchial wall
thickening as increased density of the walls of a visible bronchus.
Bronchiectasis is defined as the bronchial lumen diameter being
larger than the adjacent pulmonary artery outer diameter.
2.4 | Assessment of the novel CT scoring system
Each chest CT scan was independently scored by three investigators
(pediatric pulmonologist MP, pediatric radiologist SMA, and pediatric
registrar EB). The scans were rescored after 3 months by EB.
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2.5 | Clinical data
2.5.1 | Prenatal and neonatal data
Prenatal data were retrieved from the medical records: side of CDH,
observed over expected lung‐to‐head ratio (O/E LHR), FETO. The
O/E LHR consists of measuring the size of the lung contralateral to
the defect side divided by the fetal head circumference corrected for
gestational age and expressed as a percentage of the normal.13
Predicted severity is defined as severe if O/E LHR ≤ 25%;
moderate as O/E LHR > 25 and ≤ 35% whatever the liver position
and O/E LHR > 35%‐45% with the liver up.13
The following neonatal factors were collected: postmenstrual age
(weeks), birth weight (z scores corrected for prematurity), duration of
invasive ventilation (days), and duration of oxygen therapy (days).
2.5.2 | Assessment at age 1 year
Biometric parameters were expressed as z scores and corrected for
prematurity.8 Respiratory rate at rest (RR) was measured by MP on the
assessment at age 1 year by counting RR during 1minute in quiet state.
Feeding problems were defined as any of the following: gastro-
esophageal reflux disease at the age of 1 year (defined as a clinical
history of regurgitation and/or vomiting or the use of antacids and/or
prokinetics); oral aversion (defined as need for tube‐feeding at 1 year).
Parents completed a respiratory questionnaire validated in
children.8 The questions referred to the child’s symptoms over the
preceding 3 months and there were five graded responses, with a
maximal total score of 118.8
Additionally, the clinical impact of the information provided by
the chest CT was evaluated by reviewing if the clinical management
had been changed based on the CT result.
2.6 | Statistics
Interobserver and intraobserver reproducibility was examined using
intraclass correlation (ICC) coefficient and Bland‐Altman plots. We
considered ICC values between 0.4 and 0.6, 0.6 and 0.8, and >0.80 to
represent “moderate,” “good,” and “very good” agreement, respectively.
Correlation between CT (sub)scores and other predictors or clinical
parameters were explored with nonparametric tests (Spearman).
We did not correct the P values for multiple comparisons.
All reported P values were two‐tailed and P < .05 was considered
significant. SPSS Statistics (IBM, version 23) was used for statistical
analysis.
2.7 | Ethics
This CDH clinical follow‐up program was approved by the institu-
tional review board of the University hospital Leuven (S51085).
3 | RESULTS
The flowchart of patients included in this study is shown in Figure SI.
Of the 85 with CDH, 35 patients met the inclusion criteria; patient
demographics are shown in Table 1. The predicted severity was mild
for 12, moderate for 13, severe for 9, and 1 patient had a postnatal
diagnosis.
When we compare the 35 patients included with the
surviving patients not included (n = 18), we have more
milder cases in the included cohort (O/E LHR significantly 35.5
vs 24.7; P = .042) and significantly less FETO cases (31% vs 64%;
P = .038). This is because children referred from abroad are not
included in this study and the reason for referral is mere severity
and FETO procedure.
All 35 CT scans showed abnormalities albeit some only mild
(Table 2). The most common findings were subpleural linear and
triangular opacities. Decreased attenuation and atelectasis/consoli-
dation were present in majority of the CT scans. In decreasing order
we found ground glass opacities, bronchiectasis, and bronchial wall
thickening. Bullae and cysts were rare.
The mean total CT score was 16 (IQR: 9‐23), with the
greatest contribution from the scores for decreased attenuation
(5; IQR: 2‐8), subpleural linear and triangular opacities
(4; IQR: 3‐5) and atelectasis/consolidation (2; IQR: 1‐3). The
highest total CT score was 34 (63% of the maximal total score), the
lowest being 3 (6% of the maximal total score). The distribution of
the mean for each subscores for individual patients is shown in
Figure 1.
TABLE 1 Patient demographics
N= 35
Male/female 23/12
Gestational age, wka (n = 35) 38.0 (IQR 36.1‐38.3)
Birth weight, kga (n = 35) 3.0 (IQR 2.6‐3.3)
Birth weight z score (n = 34) −0.2 (IQR −0.7 to 0.5)
FETO treatmenta 11/35 (31%)
O/E LHR (n = 33) 36.4 (29.1‐43.0)
Days ventilated (n = 34) 11 (6‐18)
Days oxygen supplemented (n = 32) 13 (6‐24)
Age at CT scan, moa 12.3 (IQR 11.8‐13.0)
BMI z score at 1 y (n = 34) −1.6 (−2.6 to −1.1)
Total questionnaire score (n = 31) 20 (13‐32)
Respiratory rate (n = 29) 42 (35‐53)
Feeding problems (n = 34) 16/34
ECMO 0/34
Note: Patient demographics and baseline data are presented for the
cohort studied. Data are given as median and IQR for continuous values,
otherwise as proportion (%).
Abbreviations: ECMO, extracorporeal membrane oxygenation; FETO,
fetoscopic endoluminal tracheal occlusion; O/E LHR, over expected
lung‐to‐head ratio.
aCases (%).
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3.1 | Agreement
Intraobserver and interobserver agreement for the total CT score and
subscores are shown in Table 3. Between‐observer and within‐observer
agreement for the total CT score was very good (ICC >0.9). The degree
of agreement was higher for frequently observed abnormalities
(decreased attenuation, ground glass, and subpleural opacities) com-
pared with less common findings (bullae or bronchial wall thickening).
Bland‐Altman plots showed that differences between observers
were independent of the magnitude of the score (Figure SIIIa‐c).
3.2 | Correlation with proxies of clinical severity
The total CT score did not correlate with prenatally calculated
“Predicted severity” (O/E LHR) but correlated significantly with the
neonatal clinical course (duration of ventilation and the duration of
oxygen treatment) (Table 4). Infants with feeding difficulties at 1 year
of age had higher total CT scores. The total CT score correlated with
the respiratory questionnaire score but not with RR. The CT
subscores “linear opacities,” “decreased attenuation,” “ground glass
opacities,” and “atelectasis” also correlated with the duration of
neonatal oxygen treatment and of mechanical ventilation. Only
“linear opacities” and “decreased attenuation” subscores correlated
with feeding problems and the respiratory questionnaire scores.
3.3 | Clinical impact
Of 35 children, 9 had a change in approach or therapy based on CT
results (one or more of the following in each of these 9 children): start of
antibiotic therapy (n = 3), more intensive treatment with respiratory
infections (n = 3), continue nasal continuous positive airway pressure
instead of planned stop (n = 1), further investigations for sliding hernia
(n = 1), closer follow‐up because of reherniation or partial patch
dehiscence (n = 2), regular respiratory follow‐up (n = 2), institution of do
not resuscitate code (n =1), plan bronchoscopy (n = 1), reassurance (no
repercussion on CT of recurrent wheeze and rhonchi) (n = 1).
4 | DISCUSSION
We developed a CT scoring system for CDH survivors, applied this
scoring system on chest CT scans performed at the age of 1 year in a
TABLE 2 Frequency of the different chest CT findings
Finding Observer 1(%) Observer 2 (%) Observer 3 (%)
Linear/triangular subpleural opacity 34 (97.1) 35 (100) 35 (100)
Bronchiectasis 20 (57.1) 12 (34.3) 18 (51.4)
Bronchial wall thickening 35 (100) 6 (17.1) 23 (65.7)
Bullae/cyst 1 (2.9) 9 (25.7) 0 (0)
Decreased attenuation 30 (85.7) 33 (94.3) 29 (82.9)
Ground glass 21 (60) 25 (71.4) 18 (51.4)
Atelectasis/consolidation 26 (74.3) 30 (85.7) 33 (94.3)
Note: Occurrence of the different chest CT abnormalities is shown (n = number of patients with this item scored positive) as scored by the different
scorers. Data are presented as n (%).
Abbreviation: CT, computed tomography.
F IGURE 1 Distribution of different CT subscores. This figure illustrates the distribution of the mean for the different CT subscores, each dot
representing 1 patient. BW, bronchial wall; CT, computed tomography
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cohort of CDH survivors for correlation with clinical parameters. All
CT scans showed pulmonary abnormalities, ranging from minor to
severe. The most frequent findings were subpleural linear and
triangular opacities, decreased attenuation, and consolidation or
atelectasis. The proposed scoring system can differentiate between
the range of lung abnormalities found on chest CT. Moreover the
interobserver and intraobserver agreement of the scoring was
very good.
Our CDH‐CT scoring is based on a scoring system for CLD of
prematurity. CLD‐like radiological abnormalities have been pre-
viously reported in 56%‐60% of CDH survivors, independent of
gestational age. Respiratory morbidity in CDH survivors is also a
combination of sequelae from pulmonary hypoplasia and ventilator‐
induced disease.2
A detailed comparison of CT abnormalities between studies is
difficult, owing to different scoring methods, age at evaluation, CT
modalities, and the severity of disease. Studies on CT findings in CLD
of prematurity report subpleural linear and triangular opacities in
65%‐95% of the patients.10,14 These opacities represent neofissures
and strands of atelectasis formed by hyperaerated and atelectatic
zones. While bronchiectasis is rarely reported in individuals with CLD
of prematurity, almost half of the CT scans in our CDH patients
showed some degree of bronchiectasis. Bronchiectasis is far more
rare in BPD/CHD compared with CF but does occur as a
consequence of chronic infection/inflammation.12,14 The presence
of bronchial wall thickening in CLD of prematurity scoring systems
ranges from “not found at all” to “found in all CT scans reviewed.”14
The total CT score had a very good interobserver agreement. For
the more frequent findings the agreement was higher compared with
the less frequent findings. The poor interobserver agreement for
bronchial wall thickening is also common in the scoring systems for
CF.15 Intraobserver reproducibility was very good for the total CT
score and for all individual subscores. Overall, the intraobserver and
interobserver agreement results are in line with previous reports on
CT scores for both CF and CLD of prematurity.11,15
TABLE 3 Intraobserver and interobserver agreement for the total





ICC 95% CI ICC 95% CI
Total score 0.97 0.88‐0.99 0.98 0.95‐0.99
Linear/triangular
subpleural opacity
0.85 0.71‐0.93 0.72 0.50‐0.85
Bronchiectasis 0.87 0.74‐0.93 0.59 0.29‐0.78
Bronchial wall
thickening
0.84 0.67‐0.92 0.11 −0.08 to 0.35
Bullae/cyst – – 0.10 −0.54 to 0.51
Decreased
attenuation
0.93 0.83‐0.97 0.89 0.81‐0.94
Ground glass 0.93 0.86‐0.97 0.88 0.79‐0.94
Atelectasis/
consolidation
0.95 0.88‐0.97 0.89 0.70‐0.95
Note: Intraobserver and interobserver agreement is expressed as ICC (95%
CI) using ICC. We consider values between 0.4 and 0.6, 0.6 and 0.8, and
> 0.80 as “moderate,” “good,” and “very good” agreement, respectively.
Abbreviations: CI, confidence interval; ICC, intraclass correlation
coefficient.
TABLE 4 Correlation between CT scores and clinical parameters
















Total CT score 0.40 −0.231 0.081 0.750* 0.739* 0.494* −0.146 0.461* 0.270 0.424*
P = .827 P = .181 P = .651 P < .001 P < .001 P = .003 P = .409 P = .009 P = .157 P = .013




0.259 −0.279 0.108 0.714* 0.647* 0.402* −0.190 0.401* 0.269 0.217
P = .146 P = .105 P = .545 P < .001 P < .001 P = .019 P = .283 P = .025 0.158 P = .217
n = 33 n = 35 n = 34 n = 34 n = 32 n = 34 n = 34 n = 31 n = 29 n = 34
Attenuation 0.126 −0.127 0.181 0.706* 0.709* 0.324 −0.050 0.403* 0.104 0.463*
P = .484 P = .469 P = .304 P < .001 P < .001 P = .062 P = .778 P = .025 P = .595 P = .006
n = 33 n = 35 n = 34 n = 34 n = 32 n = 34 n = 34 n = 31 n = 29 n = 34
Ground glass −0.038 −0.060 0.036 0.367* 0.359* 0.367 −0.033 0.161 0.289 0.130
P = .832 P = .730 P = .840 P = .033 P = .044 P = .033 P = .854 P = .386 P = .128 P = .463
n = 33 n = 35 n = 34 n = 34 n = 32 n = 34 n = 34 n = 31 n = 29 n = 34
Atelectasis −0.027 −0.186 −0.092 0.543* 0.466* 0.394 −0.211 0.530* 0.220 0.392*
P = .882 P = .284 P = .605 P = .001 P = .007 P = .021 P = .231 P = .002 P = .251 P = .022
n = 33 n = 35 n = 34 n = 34 n = 32 n = 34 n = 34 n = 31 n = 34 n = 34
Bronchiectasis 0.189 −0.183 0.123 0.447 0.550* 0.319 −0.194 0.046 0.239 0.330
P = .292 P = .293 P = .490 P = .008 P = .001 P = .066 P = .271 P = .805 P = .212 P = .057
n = 33 n = 35 n = 34 n = 34 n = 32 n = 34 n = 34 n = 31 n = 29 n = 34
Note: Correlation between CT scores and clinical parameters were explored with nonparametric tests (Spearman). All reported values were two‐tailed and
*P < .05 was considered significant.
Abbreviations: BPD, bronchopulmonary dysplasia; BW, bronchial wall; CT, computed tomography; O/E LHR, over expected lung‐to‐head ratio; PMA, post
menstrual age.
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We found a good correlation between CT scores and important
clinical parameters such as duration of mechanical ventilation and
oxygen supplementation as well as with respiratory and feeding
morbidity at the age of 1 year. No correlation was found between the
prenatal‐predicted severity and the CT score at age 1. The clinical
impact of the chest CT results were relevant because more than 1
out of 4 CT findings resulted in a change in therapy or follow‐up.
This is to our knowledge the first systematic evaluation of chest
CT in infants born with CDH. Some long‐term follow‐up programs
report abnormalities on chest radiographs7,16,17 in more than 50%. A
very recent publication reports on spirometry‐guided chest CT in 26
patients with CDH compared with controls at a median age of 10
years using a modified Brody score.10 The main findings in this older
age group were subpleural linear and triangular markings as well as
architectural distortion. Lung scintigraphy studies document signifi-
cantly reduced lung perfusion and ventilation in the neonatal period
in the ipsilateral lung. While ventilation as assessed on the
scintigraphy studies improved over time in most studies, it is unclear
if this the result of alveolar proliferation, alveolar overexpansion, or
emphysematous changes. Several studies document a persistent
hypoperfusion which might reflect a limited vascular growth
potential.7,17,18 Lung scintigraphy has shown to be useful to predict
long‐term pulmonary morbidity and poor nutritional status.18
Quantitative lung perfusion with MRI has also been used to assess
lung perfusion at the age of 2 years without the need for ionizing
radiation (however requiring general anesthesia) with findings similar
to lung scintigraphy studies.19,20 Recently hyperpolarized 3He lung
MRI was performed in a small cohort of young adult patients treated
for CDH. Functional and microstructural changes persisting into
adulthood were documented9 and measurement of the apparent
diffusion coefficient was consistent with enlargement of the alveolar
dimensions.
To stimulate fetal lung growth, FETO has been developed. A recent
meta‐analysis supports improved survival in neonates with severe CDH
treated by FETO compared with standard perinatal management only.3
For left‐sided severe and moderate CDH, the procedure is considered
investigational and is currently being evaluated in a randomized clinical
trial (https://www.totaltrial.eu/).13 This study was not related to FETO
treatment specifically but was part of a clinical follow‐up for all CDH
patients. As our center is a FETO referral center, some patients in this
cohort have been treated with FETO but we did not aim to study this
group specifically.
There are several limitations to our study. We could not include
the CDH survivors transferred back abroad after treatment in our
center. The latter group consist of a cohort with more severe O/E
LHR and higher proportion of FETO treatment as these are the
reasons for referral to our center. In contrast, the cohort studied
better reflects the whole clinical spectrum of CDH disease.
CT scans involve extra radiation to patients already exposed to
frequent radiological imaging as neonate. The current evolution in MRI
imaging of the lung will open new and possibly safer ways for lung
imaging but will necessitate some form of sedation or anesthesia. So far,
MRI has mainly been studied for perfusion and lung volume
measurements,21 more recently also to study the structural lung
sequelae in CDH.9 Expertise gained from other diseases like CF will
expand the field of MRI lung imaging in the near future.22
CT imaging was done without controlled inspiration and expiration
scans. Although volume control is not essential for all CT scoring,23
spirometer‐guided inspiratory CT scans are considered superior for
the objective evaluation of bronchiectasis and to detect regions of
trapped air and hypoperfusion. Tracheobronchomalacia can best be
detected on expiratory scans. Of course volume control is only
feasible in children aged 5 years and above24,25 unless if performed
under general anesthesia and with cuffed endotracheal intubation.26
In our clinical follow‐up program this was not feasible nor desirable.
We neither studied pulmonary vascular development nor made
lung volume calculations. No scoring was performed for cardiac
morphology or position. Much can be learned on the use of chest CT
scoring as an outcome parameter from the context of CF where
scoring systems such as PRAGMA‐CF have been improved in
sensitivity and automatization by using a morphometric approach
and quantitative grid methods.27,28
For further validation we need to study which subscores are
likely to be clinically relevant (for example, reflect gas exchange and
correlation with lung function at a later age). For this purpose we will
expand our data set and add follow‐up data at school age including
lung function. Subscores occurring less frequently and/or proving less
relevant for outcome prediction can be left out from the scoring, like
for example, bullae.
Finally our validation lacks evaluation of external validity because
in order to do this we would have to test this scoring system in
another setting (for example a CDH cohort in other expertise centers
and scored by other scorers).
In conclusion, we developed and validated a chest CT score for
CDH survivors. Our CDH‐CT score has a good to very good
reproducibility. The correlation with clinical parameters in the
neonatal period as well as at the age of 1 year support the clinical
validity of our scoring system and its potential as future outcome
measure in clinical trials. Further follow‐up is planned at school age
including imaging, lung function testing, and exercise assessment.
These future studies will allow the evaluation of chest CT scoring as a
possible tool for predicting the prognosis of CDH survivors.
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